Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-06

Clinical Trial Update: Propranolol Combined With Novel Endocrine Therapy and Androgen Deprivation Therapy (ADT) for Neoadjuvant Treatment in High-Risk Prostate Cancer Patients: A Multicenter, Single-Arm Clinical Study [NA]

View source ↗

Summary

This multicenter, single-arm trial evaluates propranolol in combination with a novel endocrine therapy and androgen deprivation therapy as neoadjuvant treatment…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Androgen deprivation therapy (Androgen deprivation therapy)
  • Novel endocrine therapy
  • Propranolol (propranolol)

Snippet

Sponsor: Zhongda Hospital | Conditions: Prostate Cancer | NA | Status: NOT_YET_RECRUITING